---
title: "Accendra Health, Inc. (ACH) NYSE Suspends Trading, Begins Delisting Proceedings"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/305885437.md"
description: "NYSE suspended trading of Accendra Health (ACH) on Nov 16, 2026, and initiated delisting proceedings due to abnormally low selling prices. Trading resumed on OTCQB under ticker ACCH on Nov 17. This listing status change reduces liquidity and market access, reflecting severe share-price weakness."
datetime: "2026-11-17T23:30:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/305885437.md)
  - [en](https://longbridge.com/en/news/305885437.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/305885437.md)
generator: "portal-rs"
---

# Accendra Health, Inc. (ACH) NYSE Suspends Trading, Begins Delisting Proceedings

The NYSE suspended trading of Accendra Health common stock effective November 16, 2026, and began delisting proceedings over abnormally low selling prices. The stock began trading on OTCQB as ACCH on November 17.

**Material Details**

| # | Detail                                              | AI Analyst View                                                                                                 |
| - | --------------------------------------------------- | --------------------------------------------------------------------------------------------------------------- |
| 1 | NYSE trading suspended; delisting proceedings begun | The loss of NYSE listing can reduce liquidity and market access; trading has moved to the OTCQB.                |
| 2 | OTCQB trading began as ACCH on Nov. 17              | Investors must use the new OTCQB ticker and account for potentially different liquidity and trading conditions. |
| 3 | NYSE cited abnormally low selling prices            | The delisting reflects severe share-price weakness and adds a significant listing risk.                         |

**Context by AI Analyst**

This is a significant listing-status event amid the company's stated turnaround efforts, rather than a new operating or financial result. Further developments on the delisting process or a successful cure of NYSE listing noncompliance would determine whether the shares can return to the exchange.

Based on the original press release from Accendra Health, Inc. distributed by BusinessWire.

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Summary is based on content distributed by BusinessWire. Please verify any important information with the original source. This information is not a recommendation for what you should do personally and does not constitute investment advice.

### Related Stocks

- [ACCH.US](https://longbridge.com/en/quote/ACCH.US.md)

## Related News & Research

- [GIGABYTE Concludes AI Partner Summit, Showcasing Real-World AI Agent Solutions for Enterprise](https://longbridge.com/en/news/306311368.md)
- [AI solves 167-year-old maths problem, Anthropic researcher claims](https://longbridge.com/en/news/306318851.md)
- [Anthropic lacks ‘basic moral compass’, say publishers](https://longbridge.com/en/news/306295252.md)
- [Marvell Stock’s (MRVL) Plunge Is My Opportunity to Buy](https://longbridge.com/en/news/306273400.md)
- [ANALYSIS-Anthropic listing extends Nasdaq's dominant run against arch-rival NYSE](https://longbridge.com/en/news/306184666.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**